Avula Jayakumar
Research Subjects
Avula Jayakumar has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Haritha Avula
Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Telangana, India
4 shared publications- Nupur Arora
Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh, India
3 shared publications A Haritha
Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh, India
2 shared publicationsAnumala Naveen
Department of Periodontics, Sri Sai College of Dental Surgery, Andhra Pradesh, India
2 shared publicationsKalakonda Butchibabu
Department of Periodontics, Sri Sai College of Dental Surgery, Andhra Pradesh, India
2 shared publicationsA Naveen
Department of Periodontics, Sri Sai College of Dental Surgery, Vikarabad, Andhra Pradesh, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 19 (3) , 258-62
Authors, authorship order, the moving finger writes
There has been a phenomenal increase in the number of research papers with multiple authors. Increasing academic pressures and halo around individuals with prolific publications have made many aspirants to claim authorship. Increasing number of authors has brought its own issues of author credits, disputes, rivalry, and a degree of unwelcome scramble for credit sharing. Many unresolved issues about authorship and various guidelines and admonitions are more often infringed than adhered to. The position of the first and last author seem to be well recognized in medical and dental journals, but the fate of middle authors is left to guessing and often of inconsequential importance. Most of these issues, as well as fraud, misconduct in medical research publications, have been discussed amply but too of no avail. It is comforting to know that except for small shouts and whispers, dental research has been relatively free from scams and frauds. The complacency, however, needs to be tempered with constant vigil against fraud, falsification and fabrication of research reports. Honest authorship, vigilant editors, robust peer review, and a discerning readership are the sine qua non for a good research paper. Academic institutions and selection committees should be concentrating on the quality of research papers and not enamored of their number.
- 1 January 2015
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 19 (3) , 258-62
Open AccessAuthors, authorship order, the moving finger writes
There has been a phenomenal increase in the number of research papers with multiple authors. Increasing academic pressures and halo around individuals with prolific publications have made many aspirants to claim authorship. Increasing number of authors has brought its own issues of author credits, disputes, rivalry, and a degree of unwelcome scramble for credit sharing. Many unresolved issues about authorship and various guidelines and admonitions are more often infringed than adhered to. The position of the first and last author seem to be well recognized in medical and dental journals, but the fate of middle authors is left to guessing and often of inconsequential importance. Most of these issues, as well as fraud, misconduct in medical research publications, have been discussed amply but too of no avail. It is comforting to know that except for small shouts and whispers, dental research has been relatively free from scams and frauds. The complacency, however, needs to be tempered with constant vigil against fraud, falsification and fabrication of research reports. Honest authorship, vigilant editors, robust peer review, and a discerning readership are the sine qua non for a good research paper. Academic institutions and selection committees should be concentrating on the quality of research papers and not enamored of their number.
- 21 November 2012
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 40 (2) , 172-179
Efficacy of modified minimally invasive surgical technique in the treatment of human intrabony defects with or without use of rhPDGF‐BB gel – a randomized controlled trial
Aim: To evaluate the efficacy of modified minimally invasive surgical technique (M‐MIST) technique with local delivery of recombinant human platelet derived growth factor (rhPDGF‐BB) gel in the treatment of intrabony defects.Material and Methods: Twenty‐four healthy subjects were included in the present double‐blinded, randomized, controlled study. Test group was treated with M‐MIST and rhPDGF‐BB and control group with M‐MIST alone.Results: The mean probing depth (PD), clinical attachment level (CAL) and gingival recession, cementoenamel junction to base of the defect (CEJ‐BD), defect depth (DD) and cementoenamel junction to alveolar crest (CEJ‐AC), at baseline to 6 months post‐operatively in both the groups were statistically significant. Inter‐group comparison for gain in attachment level (CAL‐G), probing depth reduction (PD‐R) and change in gingival margin position linear bone growth (LBG), percentage bone fill, residual defect depth (residual DD) and the change in alveolar crest position revealed no statistically significant differences. Gain in CAL and LBG was 3 ± 0.89 mm and 1.89 ± 0.6 in test group and 2.64 ± 0.67 mm and 1.85 ± 1.18 mm in control group, respectively, and did not show statistical significance.Conclusions: The improvement in both groups could be attributed to the novel surgical technique rather than addition of rhPDGF‐BB.
- 21 November 2012
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 40 (2) , 172-179
Efficacy of modified minimally invasive surgical technique in the treatment of human intrabony defects with or without use of rhPDGF‐BB gel – a randomized controlled trial
Aim: To evaluate the efficacy of modified minimally invasive surgical technique (M‐MIST) technique with local delivery of recombinant human platelet derived growth factor (rhPDGF‐BB) gel in the treatment of intrabony defects.Material and Methods: Twenty‐four healthy subjects were included in the present double‐blinded, randomized, controlled study. Test group was treated with M‐MIST and rhPDGF‐BB and control group with M‐MIST alone.Results: The mean probing depth (PD), clinical attachment level (CAL) and gingival recession, cementoenamel junction to base of the defect (CEJ‐BD), defect depth (DD) and cementoenamel junction to alveolar crest (CEJ‐AC), at baseline to 6 months post‐operatively in both the groups were statistically significant. Inter‐group comparison for gain in attachment level (CAL‐G), probing depth reduction (PD‐R) and change in gingival margin position linear bone growth (LBG), percentage bone fill, residual defect depth (residual DD) and the change in alveolar crest position revealed no statistically significant differences. Gain in CAL and LBG was 3 ± 0.89 mm and 1.89 ± 0.6 in test group and 2.64 ± 0.67 mm and 1.85 ± 1.18 mm in control group, respectively, and did not show statistical significance.Conclusions: The improvement in both groups could be attributed to the novel surgical technique rather than addition of rhPDGF‐BB.
- 1 August 2012
- Published by Wiley in Journal of Periodontology
- Vol. 83 (8) , 1038-1047
Periodontal Findings in Patients With Oral Submucous Fibrosis and Comet Assay of Affected Gingival Epithelial Cells
Background: Oral submucous fibrosis (OSF) involves large sections of population and is related to certain chewing practices that involve direct exposure of the gingiva to noxious chemicals and additives. The impact of such practices, although studied extensively in relation to the cheek mucosa, is not elucidated as far as gingival tissues are concerned. The possible DNA damage on affected gingiva is also one of the objectives of the present study.Methods: One hundred cases of individuals with OSF and 89 without OSF were examined for periodontal parameters and compared. Biopsies of gingival tissue from both categories were examined with conventional hematoxylin and eosin staining for epithelial, connective tissue, and inflammatory changes. Comet assay of epithelial cells obtained from scraping the gingival surface of both patients with OSF and control individuals was performed.Results: Patients with OSF had poorer oral hygiene and greater loss of attachment, probing depth, and recession compared with controls. Significant histopathologic changes in the form of loss of rete ridges with gingival epithelium reduced to a flattened surface was observed. All the patients with OSF showed comet cells in larger numbers. The controls also showed comet cells but in fewer numbers, and the number of individuals showing comet cells was significantly less.Conclusion: OSF showed significant changes in affected gingiva, and the presence of comet cells in all the patients with OSF is a significant indicator of possible pathognomonic developments.
- 1 August 2012
- Published by Wiley in Journal of Periodontology
- Vol. 83 (8) , 1038-1047
Periodontal Findings in Patients With Oral Submucous Fibrosis and Comet Assay of Affected Gingival Epithelial Cells
Background: Oral submucous fibrosis (OSF) involves large sections of population and is related to certain chewing practices that involve direct exposure of the gingiva to noxious chemicals and additives. The impact of such practices, although studied extensively in relation to the cheek mucosa, is not elucidated as far as gingival tissues are concerned. The possible DNA damage on affected gingiva is also one of the objectives of the present study.Methods: One hundred cases of individuals with OSF and 89 without OSF were examined for periodontal parameters and compared. Biopsies of gingival tissue from both categories were examined with conventional hematoxylin and eosin staining for epithelial, connective tissue, and inflammatory changes. Comet assay of epithelial cells obtained from scraping the gingival surface of both patients with OSF and control individuals was performed.Results: Patients with OSF had poorer oral hygiene and greater loss of attachment, probing depth, and recession compared with controls. Significant histopathologic changes in the form of loss of rete ridges with gingival epithelium reduced to a flattened surface was observed. All the patients with OSF showed comet cells in larger numbers. The controls also showed comet cells but in fewer numbers, and the number of individuals showing comet cells was significantly less.Conclusion: OSF showed significant changes in affected gingiva, and the presence of comet cells in all the patients with OSF is a significant indicator of possible pathognomonic developments.
- Open Access
- 1 January 2012
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 16 (4) , 543-8
A randomized, double‑blind clinical study to assess the antiplaque and antigingivitis efficacy of Aloe vera mouth rinse
Aims: To evaluate the efficacy of Aloe Vera mouth rinse on experimental plaque accumulation and gingivitis. Materials and Methods: In this randomized, controlled, and double-blind study, a total of 148 systemically healthy subjects were screened in the age group of 18-25 years. Finally, 120 subjects were requested to abstain from oral hygiene (tooth brushing) for 14 days and used a specially fabricated plaque guard. Following cessation of tooth brushing in the specified area, the subjects were randomly divided into Group A (test group) who received 100% Aloe vera, Group B (negative control group) who received placebo (distilled water), and Group C (positive control group) who received 0.2% chlorhexidine. The rinse regimen began on the 15 th day and continued for 7 days. Plaque accumulation was assessed by Plaque Index (PI) and gingivitis was assessed by Modified Gingival Index (MGI) and Bleeding Index (BI) at baseline (0), 7 th , 14 th , and 22 nd days. Results: There was statistically significant decrease in PI, MGI, and BI scores after the rinse regimen began in both Group A (test group) and Group C (chlorhexidine) compared with Group B. Mouth wash containing Aloe vera showed significant reduction of plaque and gingivitis but when compared with chlorhexidine the effect was less significant. Conclusion: Aloe vera mouthwash can be an effective antiplaque agent and with appropriate refinements in taste and shelf life can be an affordable herbal substitute for chlorhexidine.
- 1 January 2012
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 16 (4) , 543-8
Open AccessA randomized, double‑blind clinical study to assess the antiplaque and antigingivitis efficacy of Aloe vera mouth rinse
Aims: To evaluate the efficacy of Aloe Vera mouth rinse on experimental plaque accumulation and gingivitis. Materials and Methods: In this randomized, controlled, and double-blind study, a total of 148 systemically healthy subjects were screened in the age group of 18-25 years. Finally, 120 subjects were requested to abstain from oral hygiene (tooth brushing) for 14 days and used a specially fabricated plaque guard. Following cessation of tooth brushing in the specified area, the subjects were randomly divided into Group A (test group) who received 100% Aloe vera, Group B (negative control group) who received placebo (distilled water), and Group C (positive control group) who received 0.2% chlorhexidine. The rinse regimen began on the 15 th day and continued for 7 days. Plaque accumulation was assessed by Plaque Index (PI) and gingivitis was assessed by Modified Gingival Index (MGI) and Bleeding Index (BI) at baseline (0), 7 th , 14 th , and 22 nd days. Results: There was statistically significant decrease in PI, MGI, and BI scores after the rinse regimen began in both Group A (test group) and Group C (chlorhexidine) compared with Group B. Mouth wash containing Aloe vera showed significant reduction of plaque and gingivitis but when compared with chlorhexidine the effect was less significant. Conclusion: Aloe vera mouthwash can be an effective antiplaque agent and with appropriate refinements in taste and shelf life can be an affordable herbal substitute for chlorhexidine.
- 1 September 2011
- Published by Wiley in Journal of Periodontology
- Vol. 82 (9) , 1383-1388
Orofacial Myiasis of the Gingiva and Nasal Cavity: A Report of Two Cases and General Review
Background: Infestation of the orofacial region with live maggots is a distressing condition and many clinicians are not aware of the existence of such an entity. Usually the condition affects individuals who are debilitated, mentally challenged, and physically not able to attend to their personal needs because of lack of psychomotor coordination.Methods: This article describes two cases of orofacial myiasis reported at a rural dental school in India. Removal of the live maggots, supportive treatment, management of the cases, and morphologic features of maggots are described.Results: Both the patients belonged to a low socioeconomic group and were physically and mentally challenged. Maggot removal improved the patients’ pain and distress, and entomologic study identified the maggots as belonging to Chrysomya bezziana.Conclusions: Oral myiasis is more prevalent than commonly believed to be and an astute practitioner should be aware of such maggots in the mouth, in cases of oral and maxillofacial trauma and in vulnerable categories of patients. These patients are not physically or mentally endowed to ward off flies or complain about worms burrowing their way into oral wounds. Occurrences of such cases are rare in developed countries and reflect the lack of special care for the vulnerable group of patients belonging to certain geographic areas.
- 1 September 2011
- Published by Wiley in Journal of Periodontology
- Vol. 82 (9) , 1383-1388
Orofacial Myiasis of the Gingiva and Nasal Cavity: A Report of Two Cases and General Review
Background: Infestation of the orofacial region with live maggots is a distressing condition and many clinicians are not aware of the existence of such an entity. Usually the condition affects individuals who are debilitated, mentally challenged, and physically not able to attend to their personal needs because of lack of psychomotor coordination.Methods: This article describes two cases of orofacial myiasis reported at a rural dental school in India. Removal of the live maggots, supportive treatment, management of the cases, and morphologic features of maggots are described.Results: Both the patients belonged to a low socioeconomic group and were physically and mentally challenged. Maggot removal improved the patients’ pain and distress, and entomologic study identified the maggots as belonging to Chrysomya bezziana.Conclusions: Oral myiasis is more prevalent than commonly believed to be and an astute practitioner should be aware of such maggots in the mouth, in cases of oral and maxillofacial trauma and in vulnerable categories of patients. These patients are not physically or mentally endowed to ward off flies or complain about worms burrowing their way into oral wounds. Occurrences of such cases are rare in developed countries and reflect the lack of special care for the vulnerable group of patients belonging to certain geographic areas.
- 6 December 2010
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 38 (2) , 163-172
Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects
The objective of the study was to evaluate the safety and efficacy of a formulation containing recombinant human platelet-derived growth factor (rhPDGF-BB) and β-tricalcium phosphate (β-TCP) in patients with periodontal defects and to compare it with those of β-TCP alone. in this double-blind, prospective, parallel, active-controlled, randomized, multi-centre clinical trial, 54 patients with periodontal osseous defects were randomly assigned to rhPDGF-BB+β-TCP or β-TCP. Following periodontal surgery, respective implantation was performed. The primary and secondary end points of treatment were evaluated at the third and the sixth month. among the outcome measures, the extent of linear bone growth (p<0.01) and per cent bone fill (p<0.004) at the sixth month over baseline were significantly higher in the rhPDGF-BB+β-TCP group when compared with the β-TCP group. Similarly, it also resulted in significantly higher area under the curve clinical attachment level gain at 0-6 months (p<0.01), CAL gain and greater reduction in probing depth at the third and the sixth month than that with β-TCP treatment alone. The incidence of adverse events was similar in both the groups and no serious adverse events were reported in any of the patients. rhPDGF-BB+β-TCP is safe and effective in the treatment of periodontal defects. It increases bone formation and soft tissue healing (clinicaltrials.gov, number NCT00496847; CTRI No.: CTRI/2008/091/000152).
- 6 December 2010
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 38 (2) , 163-172
Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects
The objective of the study was to evaluate the safety and efficacy of a formulation containing recombinant human platelet-derived growth factor (rhPDGF-BB) and β-tricalcium phosphate (β-TCP) in patients with periodontal defects and to compare it with those of β-TCP alone. in this double-blind, prospective, parallel, active-controlled, randomized, multi-centre clinical trial, 54 patients with periodontal osseous defects were randomly assigned to rhPDGF-BB+β-TCP or β-TCP. Following periodontal surgery, respective implantation was performed. The primary and secondary end points of treatment were evaluated at the third and the sixth month. among the outcome measures, the extent of linear bone growth (p<0.01) and per cent bone fill (p<0.004) at the sixth month over baseline were significantly higher in the rhPDGF-BB+β-TCP group when compared with the β-TCP group. Similarly, it also resulted in significantly higher area under the curve clinical attachment level gain at 0-6 months (p<0.01), CAL gain and greater reduction in probing depth at the third and the sixth month than that with β-TCP treatment alone. The incidence of adverse events was similar in both the groups and no serious adverse events were reported in any of the patients. rhPDGF-BB+β-TCP is safe and effective in the treatment of periodontal defects. It increases bone formation and soft tissue healing (clinicaltrials.gov, number NCT00496847; CTRI No.: CTRI/2008/091/000152).
- Open Access
- 1 January 2010
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 14 (3) , 181-5
Horizontal alveolar bone loss: A periodontal orphan
Background: Attempts to successfully regenerate lost alveolar bone have always been a clinician's dream. Angular defects, at least, have a fairer chance, but the same cannot be said about horizontal bone loss. The purpose of the present study was to evaluate the prevalence of horizontal alveolar bone loss and vertical bone defects in periodontal patients; and later, to correlate it with the treatment modalities available in the literature for horizontal and vertical bone defects. Materials and Methods: The study was conducted in two parts. Part I was the radiographic evaluation of 150 orthopantomographs (OPGs) (of patients diagnosed with chronic periodontitis and seeking periodontal care), which were digitized and read using the AutoCAD 2006 software. All the periodontitis-affected teeth were categorized as teeth with vertical defects (if the defect angle was ≤45° and defect depth was ≥3 mm) or as having horizontal bone loss. Part II of the study comprised search of the literature on treatment modalities for horizontal and vertical bone loss in four selected periodontal journals. Results: Out of the 150 OPGs studied, 54 (36%) OPGs showed one or more vertical defects. Totally, 3,371 teeth were studied, out of which horizontal bone loss was found in 3,107 (92.2%) teeth, and vertical defects were found only in 264 (7.8%) of the teeth, which was statistically significant (P<.001). Search of the selected journals revealed 477 papers have addressed the treatment modalities for vertical and horizontal types of bone loss specifically. Out of the 477 papers, 461 (96.3%) have addressed vertical bone loss, and 18 (3.7%) have addressed treatment options for horizontal bone loss. Two papers have addressed both types of bone loss and are included in both categories. Conclusion: Horizontal bone loss is more prevalent than vertical bone loss but has been sidelined by researchers as very few papers have been published on the subject of regenerative treatment modalities for this type of bone loss. This study should be an impetus for greater attention to an otherwise ubiquitous periodontal challenge.
- 1 January 2010
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 14 (3) , 181-5
Open AccessHorizontal alveolar bone loss: A periodontal orphan
Background: Attempts to successfully regenerate lost alveolar bone have always been a clinician's dream. Angular defects, at least, have a fairer chance, but the same cannot be said about horizontal bone loss. The purpose of the present study was to evaluate the prevalence of horizontal alveolar bone loss and vertical bone defects in periodontal patients; and later, to correlate it with the treatment modalities available in the literature for horizontal and vertical bone defects. Materials and Methods: The study was conducted in two parts. Part I was the radiographic evaluation of 150 orthopantomographs (OPGs) (of patients diagnosed with chronic periodontitis and seeking periodontal care), which were digitized and read using the AutoCAD 2006 software. All the periodontitis-affected teeth were categorized as teeth with vertical defects (if the defect angle was ≤45° and defect depth was ≥3 mm) or as having horizontal bone loss. Part II of the study comprised search of the literature on treatment modalities for horizontal and vertical bone loss in four selected periodontal journals. Results: Out of the 150 OPGs studied, 54 (36%) OPGs showed one or more vertical defects. Totally, 3,371 teeth were studied, out of which horizontal bone loss was found in 3,107 (92.2%) teeth, and vertical defects were found only in 264 (7.8%) of the teeth, which was statistically significant (P<.001). Search of the selected journals revealed 477 papers have addressed the treatment modalities for vertical and horizontal types of bone loss specifically. Out of the 477 papers, 461 (96.3%) have addressed vertical bone loss, and 18 (3.7%) have addressed treatment options for horizontal bone loss. Two papers have addressed both types of bone loss and are included in both categories. Conclusion: Horizontal bone loss is more prevalent than vertical bone loss but has been sidelined by researchers as very few papers have been published on the subject of regenerative treatment modalities for this type of bone loss. This study should be an impetus for greater attention to an otherwise ubiquitous periodontal challenge.
- Open Access
- 1 January 2009
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 13 (3) , 121-5
Is anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics
The use of anti-platelet therapy has reduced the mortality and morbidity of cardiovascular disease remarkably. A considerable number of patients presenting before a dentist or periodontist give a history of anti-platelet therapy. A clinical dilemma whether to discontinue the anti-platelet therapy or continue the same always confronts the practitioner. Diverse opinions exist regarding the management of such patients. While one group of researchers advise continuation of anti-platelet therapy rather than invite remote, but possible, thromboembolic events, another group encourages discontinuation for variable periods. This study aims at reviewing the current rationale of anti-platelet therapy and the various options available to a clinician, with regard to the management of a patient under anti-platelet therapy. Current recommendations and consensus favour no discontinuation of anti-platelet therapy. This recommendation, however, comes with a rider to use caution and consider other mitigating factors as well. With a large number of patients giving a history of anti-platelet therapy, the topic is of interest and helps a clinician to arrive at a decision.
- 1 January 2009
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 13 (3) , 121-5
Open AccessIs anti-platelet therapy interruption a real clinical issue? Its implications in dentistry and particularly in periodontics
The use of anti-platelet therapy has reduced the mortality and morbidity of cardiovascular disease remarkably. A considerable number of patients presenting before a dentist or periodontist give a history of anti-platelet therapy. A clinical dilemma whether to discontinue the anti-platelet therapy or continue the same always confronts the practitioner. Diverse opinions exist regarding the management of such patients. While one group of researchers advise continuation of anti-platelet therapy rather than invite remote, but possible, thromboembolic events, another group encourages discontinuation for variable periods. This study aims at reviewing the current rationale of anti-platelet therapy and the various options available to a clinician, with regard to the management of a patient under anti-platelet therapy. Current recommendations and consensus favour no discontinuation of anti-platelet therapy. This recommendation, however, comes with a rider to use caution and consider other mitigating factors as well. With a large number of patients giving a history of anti-platelet therapy, the topic is of interest and helps a clinician to arrive at a decision.